Savient PharmaceuticalsOne stock that's trending very close to triggering a major breakout trade is Savient Pharmaceuticals (SVNT), a specialty biopharmaceutical company focused on developing and commercializing Krystexxa for the treatment of chronic gout. This stock has been hammered by the sellers so far in 2012, with shares down by over 60%.
5 Stocks Poised for Breakouts
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.